Maggiolo F, Gianotti N, Comi L, Di Filippo E, et al. Rilpivirine plus cobicistat-boosted darunavir as alternative to standard three-drug therapy in HIV-infected, virologically suppressed subjects: Final results of the PROBE 2 trial. Antivir Ther 2021;26.
PMID: 35485333